Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Genesys Pharma/Novopharm Biotech agreement provides funding for antisense drug for AIDS

April 17, 1997

Retroviral protease inhibitors disclosed by DuPont Merck

April 17, 1997

HIV viral replication halted using Eukarion's antibody lipidation technology

April 16, 1997

Gilead's PMPA reduces HIV levels in clinical trials

April 14, 1997

Positive results with Viracept combination therapy

April 14, 1997

Stavudine/didanosine combination safe and effective in AIDS

April 10, 1997

Promising efficacy of combination therapy including Viracept for HIV

April 10, 1997

Pharmacia & Upjohn's Rescriptor cleared by FDA

April 8, 1997

Triangle Pharmaceuticals exercises option to acquire MKC-442

April 8, 1997

hCG potentially useful in fighting HIV

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...